Anyone notice report date is November 2022, assume it was critical for planning but now full steam ahead with marketing.
also what is the perception of cardiotoxicity damage on a scale 1 to 7, response = 11
if HR+ and HER2- First line treatments are not anthracyclines, it would be groundbreaking if Zantrene is cardio protective with Herceptin. My research is focused in this direction.
Ann: Race releases complete cardio-protection data & video, page-17
-
- There are more pages in this discussion • 220 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.89 |
Change
-0.055(2.84%) |
Mkt cap ! $326.2M | |||
| Open | High | Low | Value | Volume |
| $1.93 | $1.97 | $1.87 | $300.2K | 156.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 700 | $1.88 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.89 | 500 | 1 |
View Market Depth
| Last trade - 15.26pm 16/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |